Description
Abiratas 250mg Tablet 120’S abiratas 250mg tablets are a crucial component in the treatment of advanced-stage colorectal cancer. Each tablet contains Irinotecan, a potent antineoplastic agent that inhibits DNA synthesis and promotes apoptosis (cell death) in cancer cells. The 120 tablets in this pack provide a 1-month supply for patients undergoing chemotherapy regimens. Abiratas is indicated for use in combination with 5-fluorouracil and leucovorin to treat metastatic colorectal cancer that has progressed following initial treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens. This medication should be administered under the supervision of a healthcare professional due to its potential for severe side effects.
Reviews
There are no reviews yet.